Cargando…
Evidence of response to pembrolizumab in a patient with Lynch syndrome-related metastatic colon cancer
Patients with Lynch Syndrome (LS) are at high risk of developing colorectal cancer at an early age. Germline mutations in DNA mismatch repair genes and microsatellite instability are clear signatures of this autosomal dominant disorder. Here, we report the clinical history of a 38-year-old patient w...
Autores principales: | Salman, Pamela, Panay, Sergio, Fernández, René, Mahave, Mauricio, Soza-Ried, Cristian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6205820/ https://www.ncbi.nlm.nih.gov/pubmed/30425520 http://dx.doi.org/10.2147/OTT.S167645 |
Ejemplares similares
-
Prolonged Treatment Response to Pembrolizumab in a Patient with Pretreated Metastatic Colon Cancer and Lynch Syndrome
por: Keating, Matthew, et al.
Publicado: (2019) -
Triple-negative breast cancer: the reality in Chile and in Latin America
por: Caglevic, Christian, et al.
Publicado: (2019) -
A radiological complete response to pembrolizumab in a patient with metastatic upper urinary tract urothelial cancer and Lynch syndrome
por: Oki, Ryosuke, et al.
Publicado: (2022) -
Exceptional Response to Pembrolizumab for Treatment of Metastatic Chemorefractory Endometrial Carcinoma in a Patient with Lynch Syndrome: A Case Report
por: Batman, Samantha, et al.
Publicado: (2023) -
Metastatic Malignant Perivascular Epithelioid Cell Tumors With Microsatellite Instability Within Lynch Syndrome Successfully Treated With Anti-PD1 Pembrolizumab
por: Djerroudi, Lounes, et al.
Publicado: (2023)